Skip to main content

Session Coverage

February 24, 2020
Jafar Golzarian, MD, and Constantino Peña, MD, spoke in a session dedicated to pulmonary embolism (PE) and filters.
February 10, 2020
Two-year findings from the VIRTUS trial of the VICI venous stent (Boston Scientific) showed a primary patency rate of 79.4%. As has been seen in other trials, primary patency was higher in non-thrombotic lesions (94.6%) as compared to post-…
February 07, 2020
Endovenous stenting to relieve chronic venous disease secondary to post-thrombotic or non-thrombotic iliac vein obstruction is becoming increasingly established.
January 24, 2020
Hollywood, FL (January 23, 2020) -- Robert Lookstein, MD, presented the 6-month results of the IN.PACT AV access trial at the International Symposium on Endovascular Therapy (ISET). This study is the second pivotal drug-coated balloon (DCB) trial…
January 24, 2020
Enrollment is completed and baseline demographics available for the ABRE IDE study of the ABRE Venous Stent (Medtronic), according to principal instigator Erin Murphy, MD, director of the venous and lymphatic program at Carolinas HealthCare System's…
January 23, 2020
At two years, primary patency was 84.3% with the Venovo venous stent (BD) in iliac and femoral vein obstructions, with the rates of freedom from target lesion revascularization (TLR) and target vessel revascularization (TVR) both clocking in at 89.4…
January 21, 2020
Vascular Disease Management spoke with Raghu Kolluri, MD, MS, RVT, FSVM, President for the Society for Vascular Medicine and System Medical Director, Vascular Medicine at OhioHealth Riverside Methodist Hospital. Dr. Kolluri discussed challenges…
January 20, 2020
Iliofemoral deep venous thrombosis (DVT) causes venous outflow obstruction associated with severe symptoms of pain and swelling. These patients have a significantly increased risk for post-thrombotic syndrome and 2.4-fold increased risk of recurrent…
Back to Top